These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 1371850

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. CSF monoamine metabolites and somatostatin in Alzheimer's disease and major depression.
    Molchan SE, Lawlor BA, Hill JL, Martinez RA, Davis CL, Mellow AM, Rubinow DR, Sunderland T.
    Biol Psychiatry; 1991 Jun 01; 29(11):1110-8. PubMed ID: 1714776
    [Abstract] [Full Text] [Related]

  • 8. CSF monoamine metabolite levels in Alzheimer's and Parkinson's disease.
    Gibson CJ, Logue M, Growdon JH.
    Arch Neurol; 1985 May 01; 42(5):489-92. PubMed ID: 2581531
    [Abstract] [Full Text] [Related]

  • 9. CSF monoamine metabolites in old age dementias.
    Parnetti L, Gaiti A, Reboldi GP, Santucci C, Mecocci P, Brunetti M, Cadini D, Senin U.
    Mol Chem Neuropathol; 1992 May 01; 16(1-2):143-57. PubMed ID: 1381590
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Monoamine metabolites in normal human cerebrospinal fluid and in degenerative diseases of the central nervous system.
    González-Quevedo A, García JC, Fernández R, Fernández Cartaya L.
    Bol Estud Med Biol; 1993 May 01; 41(1-4):13-9. PubMed ID: 7521168
    [Abstract] [Full Text] [Related]

  • 12. Cerebrospinal fluid kynurenic acid in male and female controls - correlation with monoamine metabolites and influences of confounding factors.
    Nilsson LK, Nordin C, Jönsson EG, Engberg G, Linderholm KR, Erhardt S.
    J Psychiatr Res; 2007 May 01; 41(1-2):144-51. PubMed ID: 16434056
    [Abstract] [Full Text] [Related]

  • 13. Decreased monoamine metabolites in frontotemporal dementia and Alzheimer's disease.
    Sjögren M, Minthon L, Passant U, Blennow K, Wallin A.
    Neurobiol Aging; 1998 May 01; 19(5):379-84. PubMed ID: 9880039
    [Abstract] [Full Text] [Related]

  • 14. Neuropsychological test performance and CSF levels of monoamine metabolites in healthy volunteers and patients with Alzheimer's dementia.
    Nybäck H, Nyman H, Schalling D.
    Acta Psychiatr Scand; 1987 Dec 01; 76(6):648-56. PubMed ID: 2450445
    [Abstract] [Full Text] [Related]

  • 15. Cerebrospinal fluid monoamine metabolites in 114 healthy individuals 18-88 years of age.
    Blennow K, Wallin A, Gottfries CG, Karlsson I, Månsson JE, Skoog I, Wikkelsö C, Svennerholm L.
    Eur Neuropsychopharmacol; 1993 Mar 01; 3(1):55-61. PubMed ID: 7682460
    [Abstract] [Full Text] [Related]

  • 16. Gradients of CSF monoamine metabolites: a comparison between male and female volunteers.
    Nordin C, Eklundh T, Fernström V, Swedin A, Zachau AC.
    J Psychiatr Res; 1995 Mar 01; 29(2):133-40. PubMed ID: 7545235
    [Abstract] [Full Text] [Related]

  • 17. Relationships between glutamate and monoamine metabolites in cerebrospinal fluid and serum in healthy volunteers.
    Alfredsson G, Wiesel FA, Tylec A.
    Biol Psychiatry; 1988 Apr 01; 23(7):689-97. PubMed ID: 2453224
    [Abstract] [Full Text] [Related]

  • 18. Reproducibility of monoamine metabolite measurements in human cerebrospinal fluid.
    Hildebrand J, Bourgeois F, Buyse M, Przedborski S, Goldman S.
    Acta Neurol Scand; 1990 May 01; 81(5):427-30. PubMed ID: 1695809
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.